Mainz Biomed B.V. (MYNZ)
USD 2.85
(-4.53%)
USD 2.85
(-4.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 613.63 Thousand USD | 249.71% |
| 2022 | 175.46 Thousand USD | 100.02% |
| 2021 | -863.14 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 613.63 Thousand USD | 24.32% |
| 2023 Q2 | 387.17 Thousand USD | 45.53% |
| 2023 Q1 | 266.05 Thousand USD | 51.63% |
| 2023 Q3 | 493.58 Thousand USD | 27.48% |
| 2023 FY | 613.63 Thousand USD | 249.71% |
| 2022 Q2 | 36.69 Thousand USD | 0.0% |
| 2022 Q4 | 175.46 Thousand USD | 0.0% |
| 2022 FY | 175.46 Thousand USD | 100.02% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | -863.14 Million USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 100.0% |
| 2020 Q2 | -0.25 USD | 0.0% |
| 2020 Q1 | - USD | 100.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | -0.50 USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q2 | -0.50 USD | 0.0% |
| 2019 Q3 | - USD | 100.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Biodesix, Inc. | 1.4 Million USD | 56.169% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -3219.833% |
| Castle Biosciences, Inc. | 7.94 Million USD | 92.274% |
| DarioHealth Corp. | 5.06 Million USD | 87.878% |
| Exact Sciences Corporation | 127.47 Million USD | 99.519% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 99.839% |
| Illumina, Inc. | 587 Million USD | 99.895% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | 21.079% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | 97.011% |
| 23andMe Holding Co. | 12.46 Million USD | 95.077% |
| Medpace Holdings, Inc. | 1.00 USD | -61363700.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 97.46% |
| Inotiv, Inc. | 56.1 Million USD | 98.906% |
| Psychemedics Corporation | 1.00 USD | -61363700.0% |
| Prenetics Global Limited | 3.12 Million USD | 80.375% |
| Precipio, Inc. | 384 Thousand USD | -59.802% |
| RadNet, Inc. | 1.00 USD | -61363700.0% |
| Sotera Health Company | 51.98 Million USD | 98.82% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 82.057% |
| Exagen Inc. | 2.87 Million USD | 78.626% |
| Natera, Inc. | 40.75 Million USD | 98.494% |
| Aspira Women's Health Inc. | 227 Thousand USD | -170.325% |
| Neogen Corporation | 189.26 Million USD | 99.676% |
| Myriad Genetics, Inc. | 20.1 Million USD | 96.947% |
| ICON Public Limited Company | 1.00 USD | -61363700.0% |
| Bionano Genomics, Inc. | 22.89 Million USD | 97.32% |
| CareDx, Inc | 19.47 Million USD | 96.848% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 98.086% |
| Guardant Health, Inc. | 61.94 Million USD | 99.009% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | 46.067% |
| Fulgent Genetics, Inc. | 5.82 Million USD | 89.469% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 99.066% |
| Personalis, Inc. | 5.66 Million USD | 89.16% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -85.936% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 82.057% |
| MDxHealth SA | 2.77 Million USD | 77.919% |
| Prenetics Global Limited | 3.12 Million USD | 80.375% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | 76.604% |
| Trinity Biotech plc | 19.93 Million USD | 96.921% |
| Neuronetics, Inc. | 8.09 Million USD | 92.418% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -3219.833% |